CombiMatrix gains $2.2m US funding:
This article was originally published in Clinica
The US Department of Defense (DoD) has awarded a one-year, $2.2m contract to CombiMatrix to fund the further development of its microarrays for a multipathogen- and chemical-detection system, using its "on chip" electrochemical detection process. The Newport Beach, California company has demonstrated that its products can simultaneously detect toxins, viruses and bacteria using its semiconductor-based microarrays, under previously DoD-funded research programmes. These systems are currently in use at several military and government laboratories as well as civilian installations.